These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37720533)

  • 1.
    Sakaki K; Murakami T; Fujimoto H; Shimizu Y; Miyake KK; Otani D; Kiyobayashi S; Okada T; Fujimoto M; Hakata T; Yamauchi I; Shimada K; Shimizu H; Nagai K; Nakamoto Y; Inagaki N
    Front Endocrinol (Lausanne); 2023; 14():1245573. PubMed ID: 37720533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Otani D; Murakami T; Murakami S; Hanaoka I; Fujimoto H; Shimizu Y; Kawai Miyake K; Sakaki K; Ueda Y; Tanaka D; Ohno T; Shimizu H; Uyama N; Iizuka N; Yabe D; Nakamoto Y; Inagaki N
    Endocr J; 2024 Sep; 71(9):925-933. PubMed ID: 38839345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive detection of insulinoma using [
    Murakami T; Fujimoto H; Hamamatsu K; Yamauchi Y; Kodama Y; Fujita N; Fujikura J; Shimizu Y; Nakamoto Y; Kimura H; Saji H; Inagaki N
    Sci Rep; 2021 Jul; 11(1):15014. PubMed ID: 34294854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of Multiple Pancreatic Neuroendocrine Tumors Identified by 68Ga-DOTANOC and 68Ga-Exendin-4 PET/CT in a Patient with Endogenous Hyperinsulinemic Hypoglycemia and Multiple Endocrine Neoplasia 1.
    Xu J; Xu X; Zhang M; Liu W; Chen J; Song S
    Neuroendocrinology; 2024; 114(9):866-871. PubMed ID: 38471465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior Diagnostic Performance of the GLP-1 Receptor Agonist [Lys
    Senica K; Tomazic A; Skvarca A; Kolenc Peitl P; Mikolajczak R; Hubalewska-Dydejczyk A; Lezaic L
    Mol Imaging Biol; 2020 Feb; 22(1):165-172. PubMed ID: 31098984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of metastatic insulinoma by positron emission tomography with [(68)ga]exendin-4-a case report.
    Eriksson O; Velikyan I; Selvaraju RK; Kandeel F; Johansson L; Antoni G; Eriksson B; Sörensen J; Korsgren O
    J Clin Endocrinol Metab; 2014 May; 99(5):1519-24. PubMed ID: 24512490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study.
    Luo Y; Pan Q; Yao S; Yu M; Wu W; Xue H; Kiesewetter DO; Zhu Z; Li F; Zhao Y; Chen X
    J Nucl Med; 2016 May; 57(5):715-20. PubMed ID: 26795291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 68Ga-Exendin-4 PET/CT Differentiates Insulinoma From Accessory Spleen in a Patient Presenting Indeterminate MRI and 68Ga-DOTATATE PET/CT Findings.
    Pang Y; Meng T; Shang Q; Chen Z; Chen H
    Clin Nucl Med; 2022 Mar; 47(3):265-267. PubMed ID: 34507334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [(68)Ga-exendin-4 PET-CT for the localization of occult insulinomas: a prospective cohort study].
    Luo YP; Pan QQ; Li F; Yu M; Xing XP; Zhang TP; Zhao YP
    Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):837-842. PubMed ID: 30392304
    [No Abstract]   [Full Text] [Related]  

  • 10. Exendin-4-based imaging in insulinoma localization: Systematic review and meta-analysis.
    Shah R; Garg R; Majmundar M; Purandare N; Malhotra G; Patil V; Ramteke-Jadhav S; Lila A; Shah N; Bandgar T
    Clin Endocrinol (Oxf); 2021 Aug; 95(2):354-364. PubMed ID: 33386617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [
    Fujimoto H; Fujita N; Hamamatsu K; Murakami T; Nakamoto Y; Saga T; Ishimori T; Shimizu Y; Watanabe H; Sano K; Harada N; Nakamura H; Toyoda K; Kimura H; Nakagawa S; Hirai M; Murakami A; Ono M; Togashi K; Saji H; Inagaki N
    Front Endocrinol (Lausanne); 2021; 12():717101. PubMed ID: 34489868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-radiolabeled GLP-1 analog exendin-4 for PET/CT imaging of insulinoma in small animals.
    Wu H; Liang S; Liu S; Pan Y; Cheng D; Zhang Y
    Nucl Med Commun; 2013 Jul; 34(7):701-8. PubMed ID: 23652208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopic insulinoma diagnosed by 68Ga-Exendin-4 PET/CT: A case report and review of literature.
    Zhang X; Jia H; Li F; Fang C; Zhen J; He Q; Liu M
    Medicine (Baltimore); 2021 Apr; 100(13):e25076. PubMed ID: 33787590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
    Wild D; Antwi K; Fani M; Christ ER
    J Nucl Med; 2021 Jul; 62(Suppl 2):44S-50S. PubMed ID: 34230073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of
    Kalff V; Iravani A; Akhurst T; Pattison DA; Eu P; Hofman MS; Hicks RJ
    Intern Med J; 2021 Oct; 51(10):1657-1664. PubMed ID: 33314504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 68Ga DOTA-Exendin PET/CT for Detection of Insulinoma in a Patient With Persistent Hyperinsulinemic Hypoglycemia.
    Parihar AS; Vadi SK; Kumar R; Mittal BR; Singh H; Bal A; Walia R; Shukla J; Sinha SK
    Clin Nucl Med; 2018 Aug; 43(8):e285-e286. PubMed ID: 29877881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Insulinomas Using Dual-Time-Point 68Ga-DOTA-Exendin 4 PET/CT.
    Michalski K; Laubner K; Stoykow C; Omrane MA; Maecke HR; Seufert J; Goetz C; Meyer PT; Ruf J
    Clin Nucl Med; 2020 Jul; 45(7):519-524. PubMed ID: 32453080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of Hidden Insulinomas with ⁶⁸Ga-DOTA-Exendin-4 PET/CT: A Pilot Study.
    Antwi K; Fani M; Nicolas G; Rottenburger C; Heye T; Reubi JC; Gloor B; Christ E; Wild D
    J Nucl Med; 2015 Jul; 56(7):1075-8. PubMed ID: 25999434
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.